3-[(21S,22S)-16-[1-[[4-[2-[3-[[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amino]phenyl]ethynyl]phenyl]methoxy]ethyl]-11-ethyl-4-hydroxy-12,17,21,26-tetramethyl-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,4,6,8(26),9,11,13(25),14,16,18(24),19-undecaen-22-yl]propanoic acid

C62H63N7O8 — CID 162651301

IUPAC3-[(21S,22S)-16-[1-[[4-[2-[3-[[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amino]phenyl]ethynyl]phenyl]methoxy]ethyl]-11-ethyl-4-hydroxy-12,17,21,26-tetramethyl-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,4,6,8(26),9,11,13(25),14,16,18(24),19-undecaen-22-yl]propanoic acid
SMILESCCC1=C(C)C2=N/C1=C\C1=C(C)C3=C(O)C/C(=C4/N/C(=C\C5=N/C(=C\2)C(C(C)OCc2ccc(C#Cc6cccc(Nc7ncnc8cc(OCCOC)c(OCCOC)cc78)c6)cc2)=C5C)[C@@H](C)[C@@H]4CCC(=O)O)C3=N1
InChIInChI=1S/C62H63N7O8/c1-9-43-34(2)47-30-53-58(36(4)49(67-53)28-48-35(3)44(19-20-57(71)72)60(68-48)46-26-54(70)59-37(5)50(69-61(46)59)29-52(43)66-47)38(6)77-32-41-17-14-39(15-18-41)13-16-40-11-10-12-42(25-40)65-62-45-27-55(75-23-21-73-7)56(76-24-22-74-8)31-51(45)63-33-64-62/h10-12,14-15,17-18,25,27-31,33,35,38,44,68,70H,9,19-24,26,32H2,1-8H3,(H,71,72)(H,63,64,65)/b48-28-,52-29-,53-30-,60-46-/t35-,38?,44-/m0/s1
InChIKeyJHHNMPCEGCTLAR-LNOKVNOZSA-N
MW1034.23 g/mol
LogP11.27
Rot. Bonds18

About 3-[(21S,22S)-16-[1-[[4-[2-[3-[[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amino]phenyl]ethynyl]phenyl]methoxy]ethyl]-11-ethyl-4-hydroxy-12,17,21,26-tetramethyl-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,4,6,8(26),9,11,13(25),14,16,18(24),19-undecaen-22-yl]propanoic acid

3-[(21S,22S)-16-[1-[[4-[2-[3-[[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amino]phenyl]ethynyl]phenyl]methoxy]ethyl]-11-ethyl-4-hydroxy-12,17,21,26-tetramethyl-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,4,6,8(26),9,11,13(25),14,16,18(24),19-undecaen-22-yl]propanoic acid (PubChem CID 162651301) has the molecular formula C62H63N7O8 and a molecular weight of 1034.23 g/mol. Its IUPAC name is 3-[(21S,22S)-16-[1-[[4-[2-[3-[[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amino]phenyl]ethynyl]phenyl]methoxy]ethyl]-11-ethyl-4-hydroxy-12,17,21,26-tetramethyl-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,4,6,8(26),9,11,13(25),14,16,18(24),19-undecaen-22-yl]propanoic acid.

Molecular Properties

Compound Name3-[(21S,22S)-16-[1-[[4-[2-[3-[[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amino]phenyl]ethynyl]phenyl]methoxy]ethyl]-11-ethyl-4-hydroxy-12,17,21,26-tetramethyl-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,4,6,8(26),9,11,13(25),14,16,18(24),19-undecaen-22-yl]propanoic acid
PubChem CID162651301
Molecular FormulaC62H63N7O8
Molecular Weight1034.23 g/mol
Exact Mass1033.47
IUPAC Name3-[(21S,22S)-16-[1-[[4-[2-[3-[[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amino]phenyl]ethynyl]phenyl]methoxy]ethyl]-11-ethyl-4-hydroxy-12,17,21,26-tetramethyl-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,4,6,8(26),9,11,13(25),14,16,18(24),19-undecaen-22-yl]propanoic acid
SMILESCCC1=C(C)C2=N/C1=C\C1=C(C)C3=C(O)C/C(=C4/N/C(=C\C5=N/C(=C\2)C(C(C)OCc2ccc(C#Cc6cccc(Nc7ncnc8cc(OCCOC)c(OCCOC)cc78)c6)cc2)=C5C)[C@@H](C)[C@@H]4CCC(=O)O)C3=N1
InChIInChI=1S/C62H63N7O8/c1-9-43-34(2)47-30-53-58(36(4)49(67-53)28-48-35(3)44(19-20-57(71)72)60(68-48)46-26-54(70)59-37(5)50(69-61(46)59)29-52(43)66-47)38(6)77-32-41-17-14-39(15-18-41)13-16-40-11-10-12-42(25-40)65-62-45-27-55(75-23-21-73-7)56(76-24-22-74-8)31-51(45)63-33-64-62/h10-12,14-15,17-18,25,27-31,33,35,38,44,68,70H,9,19-24,26,32H2,1-8H3,(H,71,72)(H,63,64,65)/b48-28-,52-29-,53-30-,60-46-/t35-,38?,44-/m0/s1
InChIKeyJHHNMPCEGCTLAR-LNOKVNOZSA-N
XLogP11.27
TPSA190.60 Ų
H-Bond Donors4
H-Bond Acceptors14
Rotatable Bonds18
Heavy Atoms77
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001034.23
LogP ≤ 511.27
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1014

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'triple_bond', 'substructure': 'N/A'}

Analyze 3-[(21S,22S)-16-[1-[[4-[2-[3-[[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amino]phenyl]ethynyl]phenyl]methoxy]ethyl]-11-ethyl-4-hydroxy-12,17,21,26-tetramethyl-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,4,6,8(26),9,11,13(25),14,16,18(24),19-undecaen-22-yl]propanoic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Erlotinib
CID 176870
Erlotinib Hydrochloride
CID 176871
Icotinib
CID 22024915
Cudc-101
CID 24756910
CP-373413
CID 16045730
Icotinib Hydrochloride
CID 44609731
Desmethyl Erlotinib
CID 18924996
3-{[6-Methoxy-7-(2-methoxyethoxy)quinazolin-4-yl]amino}phenol
CID 5329012
EGFR/ErbB-2 inhibitor
CID 9843206
CP-373420
CID 10317566
7-(4-(3-Ethynylphenylamino)-6-methoxyquinazolin-7-yloxy)-N-hydroxyheptanamide
CID 24944855
5-(4-(3-Ethynylphenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxypentanamide
CID 24944934

Frequently Asked Questions

What is the IUPAC name of 3-[(21S,22S)-16-[1-[[4-[2-[3-[[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amino]phenyl]ethynyl]phenyl]methoxy]ethyl]-11-ethyl-4-hydroxy-12,17,21,26-tetramethyl-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,4,6,8(26),9,11,13(25),14,16,18(24),19-undecaen-22-yl]propanoic acid?
The IUPAC name of 3-[(21S,22S)-16-[1-[[4-[2-[3-[[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amino]phenyl]ethynyl]phenyl]methoxy]ethyl]-11-ethyl-4-hydroxy-12,17,21,26-tetramethyl-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,4,6,8(26),9,11,13(25),14,16,18(24),19-undecaen-22-yl]propanoic acid (CID 162651301) is 3-[(21S,22S)-16-[1-[[4-[2-[3-[[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amino]phenyl]ethynyl]phenyl]methoxy]ethyl]-11-ethyl-4-hydroxy-12,17,21,26-tetramethyl-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,4,6,8(26),9,11,13(25),14,16,18(24),19-undecaen-22-yl]propanoic acid.
What is the SMILES notation for 3-[(21S,22S)-16-[1-[[4-[2-[3-[[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amino]phenyl]ethynyl]phenyl]methoxy]ethyl]-11-ethyl-4-hydroxy-12,17,21,26-tetramethyl-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,4,6,8(26),9,11,13(25),14,16,18(24),19-undecaen-22-yl]propanoic acid?
The canonical SMILES for 3-[(21S,22S)-16-[1-[[4-[2-[3-[[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amino]phenyl]ethynyl]phenyl]methoxy]ethyl]-11-ethyl-4-hydroxy-12,17,21,26-tetramethyl-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,4,6,8(26),9,11,13(25),14,16,18(24),19-undecaen-22-yl]propanoic acid is CCC1=C(C)C2=N/C1=C\C1=C(C)C3=C(O)C/C(=C4/N/C(=C\C5=N/C(=C\2)C(C(C)OCc2ccc(C#Cc6cccc(Nc7ncnc8cc(OCCOC)c(OCCOC)cc78)c6)cc2)=C5C)[C@@H](C)[C@@H]4CCC(=O)O)C3=N1.
What is the InChIKey of 3-[(21S,22S)-16-[1-[[4-[2-[3-[[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amino]phenyl]ethynyl]phenyl]methoxy]ethyl]-11-ethyl-4-hydroxy-12,17,21,26-tetramethyl-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,4,6,8(26),9,11,13(25),14,16,18(24),19-undecaen-22-yl]propanoic acid?
The InChIKey is JHHNMPCEGCTLAR-LNOKVNOZSA-N. The full InChI is InChI=1S/C62H63N7O8/c1-9-43-34(2)47-30-53-58(36(4)49(67-53)28-48-35(3)44(19-20-57(71)72)60(68-48)46-26-54(70)59-37(5)50(69-61(46)59)29-52(43)66-47)38(6)77-32-41-17-14-39(15-18-41)13-16-40-11-10-12-42(25-40)65-62-45-27-55(75-23-21-73-7)56(76-24-22-74-8)31-51(45)63-33-64-62/h10-12,14-15,17-18,25,27-31,33,35,38,44,68,70H,9,19-24,26,32H2,1-8H3,(H,71,72)(H,63,64,65)/b48-28-,52-29-,53-30-,60-46-/t35-,38?,44-/m0/s1.
What are the key properties of 3-[(21S,22S)-16-[1-[[4-[2-[3-[[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amino]phenyl]ethynyl]phenyl]methoxy]ethyl]-11-ethyl-4-hydroxy-12,17,21,26-tetramethyl-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,4,6,8(26),9,11,13(25),14,16,18(24),19-undecaen-22-yl]propanoic acid?
3-[(21S,22S)-16-[1-[[4-[2-[3-[[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amino]phenyl]ethynyl]phenyl]methoxy]ethyl]-11-ethyl-4-hydroxy-12,17,21,26-tetramethyl-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,4,6,8(26),9,11,13(25),14,16,18(24),19-undecaen-22-yl]propanoic acid has a molecular weight of 1034.23 g/mol, XLogP of 11.27, 18 rotatable bonds, 4 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[(21S,22S)-16-[1-[[4-[2-[3-[[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amino]phenyl]ethynyl]phenyl]methoxy]ethyl]-11-ethyl-4-hydroxy-12,17,21,26-tetramethyl-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,4,6,8(26),9,11,13(25),14,16,18(24),19-undecaen-22-yl]propanoic acid is sourced from PubChem (CID 162651301), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).